Epigral share price
You have to be logged in to add this to Watchlist.- ₹1,960.75(2.93%)March 21, 2025 10:16:45 AM IST
- NSE
- BSE
- Vol : 13.62K (NSE + BSE)Last 20 day avg : 49.17 K
Epigral is trading 2.93% upper at Rs 1,960.75 as compared to its last closing price. Epigral has been trading in the price range of 1,964.20 & 1,902.60. Epigral has given 0.48% in this year & 6.29% in the last 5 days. Epigral has TTM P/E ratio 22.82 as compared to the sector P/E of 17.54.There are 1 analysts who have initiated coverage on Epigral. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 103.63 Crores in its last quarter.Listed peers of Epigral include Anupam Rasayan India (-0.70%), Alkyl Amines Chemicals (1.64%), Epigral (2.93%).The Mutual Fund holding in Epigral was at 4.15% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Epigral was at 3.01% in 31 Dec 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 21, 2025, 04:49 AM UTC
- Dividend YieldLower than industry0.39Annual dividends as a percentage of the stock price.
- P/BHigher than historical values6.31The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values22.93Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.61Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.77The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 36.84% from Rs 645.24 crore to Rs 471.52 crore, year-on-year
- The company has grown its December quarter profit by 111.13% from Rs 49.08 crore to Rs 103.63 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
- R1
- 1,849.70
- R2
- 2,098.50
- R3
- 2,270.05
- S1
- 1,429.35
- S2
- 1,257.80
- S3
- 1,009.00
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Anupam Rasayan India | Bullish | 770.00 | -0.70 | 8,455.50 | 67.69 | 3.1 | 0.16 | 8.62 |
| Alkyl Amines Chemicals | Bearish | 1,619.15 | 1.64 | 8,279.69 | 54.00 | 6.45 | 0.63 | 0.15 |
| Epigral | Bullish | 1,960.75 | 2.93 | 8,460.12 | 39.96 | 6.24 | 0.20 | 43.63 |
| Sudarshan Chemicals Industries | Bullish | 1,014.95 | 3.01 | 7,974.75 | 62.63 | 6.07 | 0.46 | 18.80 |
| Galaxy Surfactants | Moderately Bearish | 2,171.85 | 1.04 | 7,673.96 | 25.50 | 3.49 | 0.84 | 4.27 |
- Promoter(s) holds a high stake in the company at 68.94%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.01 percentage points from previous quarter
- Mutual Funds holding has increased by 0.47 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-01-27 | Quarterly Results & Interim Dividend |
| 2024-11-09 | Quarterly Results |
| 2024-08-14 | To consider Fund Raising |
| 2024-07-24 | Quarterly Results |
| 2024-04-22 | Audited Results & Final Dividend |
- IndustryChemical Manufacturing
- ISININE071N01016
- BSE Code543332
- NSE CodeMFL
Epigral is trading at 1960.75 as on Fri Mar 21 2025 04:46:45. This is 2.93% upper as compared to its previous closing price of 1904.85.
The market capitalization of Epigral is 8460.12 Cr as on Fri Mar 21 2025 04:46:45.
The average broker rating on Epigral is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Epigral is 2408.35 whereas the 52 wk low is 996.80
Epigral can be analyzed on the following key metrics -
- TTM P/E: 22.82
- Sector P/E: 17.54
- Dividend Yield: 0.39%
- D/E ratio: -
Epigral reported a net profit of 195.87 Cr in 2024.
The Mutual Fund Shareholding was 4.15% at the end of 31 Dec 2024.